Case Studies

CALIXAR produces high-quality, native, wild-type, unaltered, unmutated and untruncated targets for antibody development and pharmaceutical discovery. Find out what makes us unparalleled and at the forefront of native membrane protein stabilization technology.

Adenosine Receptor (A2A)

Bacilus subtilis multidrug resistance ABC transporter BMR


Bcl-2 Associated Athanogene 3 (BAG3)

Influenza Matrix Protein 2 (M2)

Influenza A – H1N1 vaccinal preparation

K-Cl co-transporter 2 (KCC2)

Voltage-gated Sodium Channel (Nav1.7)